Dr. Anjay Rastogi joins XORTX Therapeutics CAB

XORTX Therapeutics

Dr. Anjay Rastogi has joined the clinical advisory board of XORTX Therapeutics (CSE:XRX; OTCQB:XRTXF), bringing professional experience as a thought leader, combined with clinical experience treating patients with autosomal dominant polycystic kidney disease and diabetic nephropathy.

Dr. Rastogi is a Prof. and clinical chief of nephrology at the David Geffen School of Medicine at UCLA and a director of the CORE Polycystic Kidney Disease Center at UCLA.

He is board certified in nephrology and has a doctoral degree in pharmacology. His research interests include adult polycystic kidney disease, Fabry’s Disease, Alport Syndrome and diabetic kidney disease.
Dr. Rastogi did his internal medicine residency and nephrology fellowship at UCLA and completed his graduate training under the mentorship of Nobel Laureate Professor, Louis Ignarro also at UCLA.

Sign up for the BioTuesdays weekly newsletter

Get the latest news on the healthcare industry’s corporate and clinical developments, executive moves, and market updates. Every Tuesday, in your inbox.